发明授权
- 专利标题： Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
- 专利标题（中）： 使用糖皮质激素衍生物眼科治疗选择性穿透后段组织
-
申请号： US11550642申请日： 2006-10-18
-
公开(公告)号： US08062657B2公开(公告)日： 2011-11-22
- 发明人: Jeffrey L. Edelman , Kelly M. Harrison
- 申请人： Jeffrey L. Edelman , Kelly M. Harrison
- 申请人地址： US CA Irvine
- 专利权人： Allergan, Inc.
- 当前专利权人： Allergan, Inc.
- 当前专利权人地址： US CA Irvine
- 代理机构： Allergan, Inc.
- 代理商 Joel B. German; Debra D. Condino
- 主分类号： A61F2/14
- IPC分类号： A61F2/14
摘要：
Ophthalmically therapeutic materials, such as liquid-containing compositions and polymeric drug delivery systems, include a therapeutic component that includes an Glucocorticoid Derivative which, upon delivery to the posterior segment of a mammalian eye, does not significantly diffuse to the anterior segment of said eye. Methods of making and using the present materials are also described.
公开/授权文献
信息查询
IPC分类:
